Want to see ATYR full AI Analyst Report?
aTyr Pharma (ATYR) Income Statement
aTyr Pharma Income Statement
Last quarter (Q2 2026), aTyr Pharma's total revenue was $0.00. In Q2, aTyr Pharma's net income was $-10.31M. See aTyr Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 190.00K | $ 235.00K | $ 353.00K | $ 10.39M | $ 0.00 | |
| $ -1.36M | $ 235.00K | $ 353.00K | $ 8.69M | $ -1.30M | |
| $ 76.26M | $ 68.15M | $ 55.27M | $ 55.09M | $ 32.71M | |
| Depreciation and Amortization | $ 1.55M | $ 1.54M | $ 2.74M | $ 1.70M | $ 1.30M |
| $ -72.56M | $ -62.48M | $ -47.66M | $ -43.65M | $ -32.47M | |
| $ -77.63M | $ -67.91M | $ -54.92M | $ -46.40M | $ -34.02M | |
| $ 3.51M | $ 3.89M | $ 4.52M | $ 1.06M | $ 238.00K | |
| $ -74.12M | $ -64.02M | $ -50.40M | $ -45.34M | $ -33.78M | |
| $ -74.12M | $ -64.02M | $ -50.39M | $ -45.34M | $ -33.77M | |
| Per Share Metrics | |||||
| Basic EPS | $ -32.00 | $ -34.40 | $ -37.60 | $ -64.00 | $ -70.80 |
| Diluted EPS | $ -32.00 | $ -34.40 | $ -37.60 | $ -64.00 | $ -70.80 |
| Weighted Average Shares Outstanding | 2.32M | 1.86M | 1.34M | 710.49K | 477.02K |
| Weighted Average Shares Outstanding (Diluted) | 2.32M | 1.86M | 1.34M | 710.49K | 477.02K |
Currency in USD
